The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians against selling or purchasing fake Combiart dispersible tablets (20/120 mg) in circulation.
NAFDAC in a statement indicated that the product is manufactured by Strides Arcolab Limited in India.
The agency’s officers from the post-marketing surveillance directorate discovered the counterfeit product in the Federal Capital Territory (FCT) and Rivers State.
NAFDAC said its database of registered products has confirmed that the product’s license has expired and that the registration number on it was incorrect.
“The laboratory report of the analysis carried out on the product revealed that it contained zero APIs. The product was also observed to have two different date markings,” NAFDAC said.
“Counterfeit or falsified medicines endanger people’s health because they do not comply with regulatory standards, which means the safety, quality, and efficacy of these products are not ensured.
“The use of counterfeit medicines often fails to effectively treat diseases or conditions, leading to serious health consequences, including death.”
NAFDAC said a laboratory analysis revealed that the product contained no active pharmaceutical ingredients (APIs). Additionally, it was noted that the product bore two different date markings.
The agency urged importers, distributors, retailers, healthcare professionals, and caregivers to exercise caution and remain vigilant throughout the supply chain to prevent the importation, distribution, sale, and use of counterfeit products.
